---
title: "GE HealthCare Technologies Inc. (GEHC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GEHC.US.md"
symbol: "GEHC.US"
name: "GE HealthCare Technologies Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T09:31:44.439Z"
locales:
  - [en](https://longbridge.com/en/quote/GEHC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GEHC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GEHC.US.md)
---

# GE HealthCare Technologies Inc. (GEHC.US)

## Company Overview

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women’s health products.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.gehealthcare.com](https://www.gehealthcare.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.45)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 49 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 5.96% |  |
| Net Profit YoY | -12.55% |  |
| P/B Ratio | 2.63 |  |
| Dividend Ratio | 0.23% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 28012236181.88 |  |
| Revenue | 20979000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.23% | A |
| Profit Margin | 9.10% | B |
| Gross Margin | 38.53% | B |
| Revenue YoY | 5.96% | C |
| Net Profit YoY | -12.55% | D |
| Total Assets YoY | 10.54% | B |
| Net Assets YoY | 15.71% | B |
| Cash Flow Margin | 106.18% | C |
| OCF YoY | 5.96% | C |
| Turnover | 0.59 | B |
| Gearing Ratio | 70.65% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - GE HealthCare Technologies Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "5.96%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.55%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.63",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.23%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "28012236181.88",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "20979000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.23%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "9.10%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "38.53%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "5.96%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.55%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "10.54%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "15.71%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "106.18%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "5.96%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.59",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "70.65%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 14.67 | 9/183 | 16.86 | 15.60 | 15.00 |
| PB | 2.63 | 68/183 | 3.73 | 3.54 | 3.28 |
| PS (TTM) | 1.34 | 33/183 | 1.80 | 1.70 | 1.62 |
| Dividend Yield | 0.23% | 19/183 | 0.19% | 0.18% | 0.17% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **20**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 10 | 50% |
| Overweight | 2 | 10% |
| Hold | 6 | 30% |
| Sell | 1 | 5% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 61.58 |
| Highest Target | 98.00 |
| Lowest Target | 65.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GEHC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GEHC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/GEHC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GEHC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**